Researchers have discovered an approach to identify blood biomarkers that could predict the risk of suicide in patients with depression, bringing them one step closer to developing a potential blood test for use on future patients thanks to a study by researchers at the University of California–Irvine (UCI) and Pritzker Research Consortium.
Suicides have increased to nearly 50,000 deaths yearly in the United States and around 800,000 total globally, according to the team’s research now published in Translational Psychiatry, a peer-reviewed medical journal launched in 2011. The 2022 study further shows clinical depression as the most common diagnosis among suicides.
